Showing results (11-20 of 725) with videos related to
Sort By:
Pageof 73
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
Effects of the new oral angiotensin converting enzyme inhibitor MK-421 in human hypertensionH Gavras, J Biollaz, B Waeber, et al.Lancet (London, England)|September 30, 1978
Innappropriate renin secretion unmasked by captopril (SQ 14 225) in hypertension of chronic renal failureH R Brunner, B Waeber, J P Wauters, et al.Clinical Science and Molecular Medicine. Supplement|December 1, 1978
Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitorH R Brunner, H Gavras, G A Turini, et al.Clinical Nephrology|August 1, 1981
Uncontrollable hypertension in patients on hemodialysis: long-term treatment with captopril and salt subtractionJ P Wauters, B Waeber, H R Brunner, et al.Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association|January 1, 1979
Captopril and salt subtraction to treat "uncontrollable" hypertension in haemodialysis patientsJ P Wauters, B Waeber, H R Brunner, et al.Schweizerische Medizinische Wochenschrift|December 11, 1976
[Angiotensin II inhibitors for the diagnosis and treatment of hypertension]H R Brunner, H GavrasThe American Journal of Medicine|November 1, 1980
Is the renin system necessary?H R Brunner, H GavrasHypertension (Dallas, Tex. : 1979)|March 1, 1980
Discrepancy between antihypertensive effect and angiotensin converting enzyme inhibition by captoprilB Waeber, H R Brunner, D B Brunner, et al.Hypertension (Dallas, Tex. : 1979)|March 7, 2001
Role of angiotensin and its inhibition in hypertension, ischemic heart disease, and heart failureH Gavras, H R BrunnerBlood Pressure Monitoring|November 5, 1999
Clinical value of ambulatory blood pressure monitoring in the assessment of antihypertensive therapyB Waeber, H R BrunnerPageof 73